Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Effects of nitrogen pollution on pollen allergies in Belgium

Official title: Impacts of Nitrogen Deposition in the Natural Environment on Pollen Allergy in Belgium

Run by Universitaire Ziekenhuizen KU Leuven · NCT06714149 · Data updated 2026-11-12

This study is testing how nitrogen pollution affects allergy symptoms in people who are sensitive to pollen in Belgium.

More Pollen Allergy trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment200 (estimated)
SponsorUniversitaire Ziekenhuizen KU Leuven
Academic / other
Locations1 site (Leuven, Vlaams-Brabant)
StatusRecruiting
StartedJune 29, 2022
Main results expectedFebruary 2025
Study endsApril 2025
Registry record updatedDecember 3, 2024
Trial IDNCT06714149 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals with a positive skin prick test for grass and/or birch pollen.

Probably not a fit

Patients who have undergone desensitization therapy in the last two years may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates how nitrogen enrichment in the environment affects allergy symptoms in individuals sensitized to pollen. It involves analyzing allergen-specific IgE reactivity in pollen-allergic patients and comparing their responses to various pollen samples. The study will assess basophil degranulation thresholds and the qualitative and quantitative reactivity to different pollen fragments. Additionally, it aims to correlate allergy symptoms with the reactivity to these pollen samples.

Why it matters

Potential benefit: If successful, this study could lead to improved understanding and management of pollen allergies in relation to environmental factors.

How similar studies have gone: While studies on environmental impacts on allergies exist, this specific focus on nitrogen deposition and its direct effects on pollen allergy is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Positive skin prick test for grass and/or birch pollen

Exclusion Criteria:

* Desensitization therapy during the last two years

Where it's running

  • University Hospitals Leuven
    Leuven, Vlaams-Brabant, Belgium
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Testing B-regulatory Cells as a Marker for Allergen Immunotherapy Response

    This study tests whether changes in blood B-regulatory cells can signal successful allergen immunotherapy in adults with pollen, dust mite, or insect venom allergies.

    Recruiting Hull University Teaching Hospitals NHS Trust · Hull, East Yorkshire · NCT06876506

  • Outdoor resistance training for older adults

    This trial tests a 6-week outdoor strength program using benches and a smartphone app to see if it’s safe, usable, and appealing for community-dwelling adults aged 65 and older.

    Recruiting Universitaire Ziekenhuizen KU Leuven · Leuven, Vlaams-Brabant · NCT07928687

  • Sarcopenia in Patients After Cardiac Surgery

    This observational study tests how common sarcopenia is after cardiac surgery and whether current care helps improve muscle mass and function.

    Recruiting Universitaire Ziekenhuizen KU Leuven · Leuven · NCT07908472

  • Imaging endometriosis with a special PET tracer in adult women

    This study tests whether a PET/CT scan using [18F]AlF-FAPI-74 can help detect endometriosis lesions in women who are planning laparoscopy.

    Recruiting Universitaire Ziekenhuizen KU Leuven · Leuven · NCT07876648

  • GLP-1 weight‑loss medicine: finding who will benefit most

    This study tests whether a GLP-1 drug called semaglutide helps with weight loss by changing eating behavior, to see which people it helps the most.

    Recruiting Phase 4 Universitaire Ziekenhuizen KU Leuven · Leuven · NCT07870538

  • AI-guided treatment choices for advanced liver cancer

    Researchers are testing an AI tool to help predict which patients with advanced hepatocellular carcinoma will respond to modern systemic therapies.

    Recruiting at 5 sites Universitaire Ziekenhuizen KU Leuven · Anderlecht and 4 other locations · NCT07863258

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.